Type 2 & other diabetes

Dose-related effects of intraduodenal quinine on plasma glucose, glucoregulatory hormones and gastric emptying of a nutrient drink, and energy intake, in men with type 2 diabetes: a double-blind, randomised, crossover study

DiabetologiaPublished Randomised crossover trial

Primary result · Peak plasma glucose after nutrient drink (part A)Result — go to the resultReduction in peak plasma glucose 2.8±0.6 mmol/l

Authors' conclusion

In type 2 diabetes, acute intraduodenal administration of quinine markedly reduces the plasma glucose response to oral carbohydrate, but does not affect energy intake. These findings support the potential use of quinine to reduce postprandial blood glucose levels in type 2 diabetes.

Study context

Population
Men with T2D (age 68±5 years; HbA1c 49.0±5.0 mmol/mol [6.7±0.4%]; BMI 30±1 kg/m²)parts A and B, n=12 each
Comparison
Intraduodenal quinine hydrochloride 300 mg or 600 mg vs control
Methodological detailsdouble-blind, two study parts (A and B)
  • Double-blind
  • Two study parts (A and B)

Primary result

As reported in the abstract

Peak plasma glucose after nutrient drink (part A)

Reduction in peak plasma glucose

2.8±0.6 mmol/l

P < 0.05

Further findings

Gastric emptying of nutrient drink (13C-acetate breath test)

Both quinine doses slowed gastric emptying (p<0.05)
  • n=11

Plasma GLP-1 and C-peptide

QHCl-600, but not QHCl-300, stimulated plasma GLP-1 and C-peptide modestly (both p<0.05)

Quinine alone (before drink) · 30 min after quinine

Quinine alone had no effect

Energy intake at buffet-lunch (part B)

Quinine did not affect energy intake

Original publication

Dose-related effects of intraduodenal quinine on plasma glucose, glucoregulatory hormones and gastric emptying of a nutrient drink, and energy intake, in men with type 2 diabetes: a double-blind, randomised, crossover study. Diabetologia. Published 18 December 2024. doi:10.1007/s00125-024-06344-9

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.